Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 111

Results For "launch"

2679 News Found

Cubo set to transform decentralised diagnostics with Compact RT-PCR innovation
Healthcare | April 29, 2026

Cubo set to transform decentralised diagnostics with Compact RT-PCR innovation

Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform


NADMED Limited appoints James Lee as CEO to drive global expansion
People | April 29, 2026

NADMED Limited appoints James Lee as CEO to drive global expansion

Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation


Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report
Biopharma | April 28, 2026

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation


OMRON Healthcare to donate 3,000 blood pressure monitors globally for hypertension screening
Healthcare | April 28, 2026

OMRON Healthcare to donate 3,000 blood pressure monitors globally for hypertension screening

The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries


AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
News | April 28, 2026

AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care

The approval was driven by data from the Phase III TULIP-SC trial


Sun Pharma to acquire Organon in $11.75 billion all-cash deal
News | April 27, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally


Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science
News | April 27, 2026

Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science

nSEPIA aims to bring structure to an area long dominated by subjectivity


BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price
Supply Chain | April 27, 2026

BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price

The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


New genomics clinic by Fortis Hospitals targets early disease detection
Healthcare | April 24, 2026

New genomics clinic by Fortis Hospitals targets early disease detection

New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care